XenoGesis has confirmed that it will be exhibiting at the 16th Annual Anglonordic Life Science Conference in London this May.
Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
The one-day London conference will feature panel discussions, parallel technology and biotech investment rooms, plus 1:1 meetings.
Delegates will have the opportunity to network with decision makers from leading and upcoming drug discovery and technology companies as well as investors; learn about the current status of European investment in life science technologies; and gain valuable insights from life science operators within the Anglo-Nordic space.
The event takes place at County Hall in London and opens with a reception on the 8th May, and the conference and exhibition on the 9th May.
To find out more, visit the website.